Colorectal Cancer Clinical Trials in Philadelphia

Showing 161-169 of 169 trials

Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

NCT00017082

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of oxaliplatin in treating patients who have recurrent metastatic colorectal cancer.

Colorectal Cancer

Prologue Research InternationalStarted Apr 2001

Washington D.C., District of Columbia, United States • Boca Raton, Florida, United States • Louisville, Kentucky, United States +7 more locations

COMPLETEDPHASE2< 1 mile

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

NCT00006786

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Bevacizumab may stop the growth of colorectal cancer by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus bevacizumab in treating patients who have advanced colorectal cancer.

Colorectal Cancer

Eastern Cooperative Oncology GroupStarted Nov 2000

Scottsdale, Arizona, United States • Duarte, California, United States • Palo Alto, California, United States +74 more locations

Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

Colorectal Cancer Trials in Other Cities

Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

Study of XL281 in Adults With Solid Tumors

GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

Other Conditions in Philadelphia